Loading...
tr eur-usd
EURO/USD
-0.22%
Euro US Dollar
1,05 TRY
btc
BTC
1.82%
Bitcoin
98.346,54 USDT
eth
ETH
2.3%
Ethereum
3.711,70 USDT
bch
BCH
3.19%
Bitcoin Cash
532,83 USDT
xrp
XRP
-0.58%
Ripple
2,36 USDT
ltc
LTC
2.32%
Litecoin
112,33 USDT
bnb
BNB
1.78%
Binance Coin
688,85 USDT
sol
SOL
5.26%
Solana
224,84 USDT
avax
AVAX
1.65%
Avalanche
45,34 USDT
ada
ADA
0.05%
Cardano
1,02 USDT
dot
DOT
2.48%
Polkadot
8,60 USDT
doge
DOGE
1.99%
Dogecoin
0,40 USDT
shib
SHIB
1.55%
Shiba Inu
0,00 USDT
KriptoBoss.com
featured
  1. News
  2. Altcoin News
  3. ADA and Ethereum Altcoin LNEX Targeted for Gains as Injective Price Slows – Investor Focus Shifts!

ADA and Ethereum Altcoin LNEX Targeted for Gains as Injective Price Slows – Investor Focus Shifts!

Share

Share This Post

or copy the link

Upbit Lists Injective (INJ) on KRW and USDT Markets, Price Surges

Upbit Boosts Injective (INJ) Price with New Listing

New Listing on Upbit Sparks Double-Digit Price Surge

Injective (INJ) received a significant price boost after being listed on Upbit’s KRW and USDT markets. The price surged by over 10% and briefly hit $23 before settling at $21.67.

Market Capitalization and Trading Volume Soar

Following the listing on Upbit, Injective’s market capitalization rose to $2.10 billion, and its 24-hour trading volume increased by 108.69% to $256.16 million.

Analysts Bullish on Injective (INJ) Price Prospects

Price Prediction: Injective (INJ) Expected to Reach $24

Market analysts are optimistic about Injective’s future price potential, with predictions that it could soon reach $24, potentially setting a new all-time high.

Upbit Support Enhances Liquidity and Attracts Traders

Upbit’s support has significantly boosted liquidity for Injective, making it more appealing to new traders. This increased activity is expected to drive prices higher in the days to come.

0
i_like
I like
0
dikkatimi_ekti
Dikkatimi Çekti
0
do_ru_bilgi
Doğru Bilgi
0
e_siz_bilgi
Eşsiz Bilgi
0
alk_l_yorum
Alkışlıyorum
0
sevdim
Sevdim
ADA and Ethereum Altcoin LNEX Targeted for Gains as Injective Price Slows – Investor Focus Shifts!
Comment
Disclaimer:

The information in the article is for informational purposes only. It does not constitute any investment advice. The author and CryptoBlockNews.com are not responsible for your profits or losses arising from your investments. Investment is ultimately based on many foundations such as knowledge, accumulation, experience, research and personal decisions.
ADS Banner

Your email address will not be published. Required fields are marked *

ADS Banner